Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754.26 firm fixed price delivery order by the Defense Logistics Agency to supply 50mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for performance in Conshohocken, Pennsylvania from August 4-7, 2023. As the prime contractor for delivery order under an unspecified agency-wide contract vehicle, Amerisourcebergen will fulfill the Defense Logistics Agency's requirement for this...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone treatment, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and provisioning medical...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $502,860 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for performance at its Conshohocken, Pennsylvania facility from August 7-8, 2023. As the prime contractor under an existing DLA pharmaceuticals contract vehicle, Amerisourcebergen will fulfill this order for the stocking of prescription...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $533 delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The firm fixed price contract was issued utilizing the DLA's Pharmaceutical Prime Vendor program, which centrally manages pharmaceuticals for the Department of Defense and other...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $860 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a testosterone replacement drug. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 30th to August 31st, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, responsible for...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $334.47 firm fixed price delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication, for performance at its Conshohocken, Pennsylvania facility from July 21-24, 2023. The award is issued against the DLA's pharmaceutical prime vendor contract vehicle to support the medical readiness of DOD personnel. No subcontractors...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $1,005.68 to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with all supplies delivered by October 31, 2023. This order was awarded against an unidentified medical supply vehicle and no set-aside provision was specified. As a leading...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251,420 delivery order by the Defense Logistics Agency to supply XYOSTED 75 MG/0.5 ML auto-injectors. Performance will take place in Conshohocken, Pennsylvania under firm fixed pricing over a period of four days from August 4th through the 7th of 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and...
The Defense Logistics Agency awarded a $502,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy. The single order is for product delivery to a facility in Conshohocken, Pennsylvania by August 15, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will perform as the prime contractor, with product sourcing and delivery managed through its Corporate Office...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on August 29, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...